Nanotechnology Now - News Story: Nanometrics Believes Patent Infringement Claim Has No Merit

Home > News > Nanometrics Believes Patent Infringement Claim Has No Merit

September 6th, 2005

Nanometrics Believes Patent Infringement Claim Has No Merit

Abstract:
Nanometrics Incorporated today announced that it has received notice of a patent infringement lawsuit brought by KLA-Tencor Corporation (KLAC).

Source:
businesswire

Bookmark:

Related News Press

Announcements

A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026

Qjump: Shallow-circuit quantum sampling guides combinatorial optimization On up to 104 superconducting qubits, Qjump assists in searching the ground states of hard Ising problems and might outperform simulated annealing on near-term quantum hardware April 17th, 2026

Rice study resolves decades-old mystery in organic light-emitting crystals: Findings reveal how molecular defects can enhance light conversion efficiency: April 17th, 2026

UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026

Tools

Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026

From sensors to smart systems: the rise of AI-driven photonic noses January 30th, 2026

Gap-controlled infrared absorption spectroscopy for analysis of molecular interfaces: Low-cost spectroscopic approach precisely analyzes interfacial molecular behavior using ATR-IR and advanced data analysis October 3rd, 2025

Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE